Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer-Reference-Cited by-同舟云学术

Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer

Published:2014-06-30 Issue:7 Volume:7 Page:779-796
ISSN:1424-8247
Container-title:Pharmaceuticals
language:en
Short-container-title:Pharmaceuticals

Author:

Eder Matthias,Neels Oliver,Müller Miriam,Bauder-Wüst Ulrike,Remde Yvonne,Schäfer Martin,Hennrich Ute,Eisenhut Michael,Afshar-Oromieh Ali,Haberkorn Uwe,Kopka Klaus

Publisher

MDPI AG

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

http://www.mdpi.com/1424-8247/7/7/779/pdf

Reference37 articles.

1. Mortality Results from a Randomized Prostate-Cancer Screening Trial

2. Prostate Cancer: Role of SPECT and PET in Imaging Bone Metastases

3. Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

4. PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions

5. [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH

Cited by 325 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “One Method to Label Them All”: A Single Fully Automated Protocol for GMP-Compliant ⁶⁸Ga Radiolabeling of PSMA-11, Transposable to PSMA-I&T and PSMA-617;Current Radiopharmaceuticals;2024-09

2. Cancer Theranostics: Pharmaceutical View;Pharmaceutical Science;2024-08-21

3. Impact of ⁶⁸Ga-PSMA PET/CT on Survival and Management in Prostate Cancer;Current Medical Imaging Formerly Current Medical Imaging Reviews;2024-04-26

4. Automated radiolabelling of [68Ga]Ga-PSMA-11 (gallium (68Ga)-gozetotide) using the Locametz® kit and two generators;EJNMMI Radiopharmacy and Chemistry;2024-04-17

5. Long-Term Tumor-Targeting Effect of E. coli as a Drug Delivery System;Pharmaceuticals;2024-03-26